- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2012 (2012), Article ID 134723, 8 pages
Effect of Antioxidant Mineral Elements Supplementation in the Treatment of Hypertension in Albino Rats
1Biochemistry Department, Usmanu Danfodiyo University, PMB, Sokoto 2346, Nigeria
2Faculty of Veterinary Medicine, Usmanu Danfodiyo University, PMB , Sokoto 2346, Nigeria
Received 15 April 2012; Accepted 21 May 2012
Academic Editor: Adrian Manea
Copyright © 2012 S. A. Muhammad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. J. L. Murray and A. D. Lopez, “Mortality by cause for eight regions of the world: global burden of disease study,” Lancet, vol. 349, no. 9061, pp. 1269–1276, 1997.
- R. Rodrigo, W. Passalacqua, J. Araya, M. Orellana, and G. Rivera, “Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension,” Journal of Cardiovascular Pharmacology, vol. 42, no. 4, pp. 453–461, 2003.
- K. Miyajima, S. Minatoguchi, Y. Ito et al., “Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension,” Hypertension Research, vol. 30, no. 4, pp. 307–313, 2007.
- B. R. Winkelmann, J. Hager, W. E. Kraus et al., “Genetics of coronary heart disease: current knowledge and research principles,” American Heart Journal, vol. 140, no. 4, pp. S11–S26, 2000.
- B. Rassler, “The renin-angiotensin system in the development of salt-sensitive hypertension in animal models and humans,” Pharmaceuticals, vol. 3, no. 4, pp. 940–960, 2010.
- S. Oparil, M. A. Zaman, and D. A. Calhoun, “Pathogenesis of hypertension,” Annals of Internal Medicine, vol. 139, no. 9, pp. 761–776, 2003.
- E. Grossman, “Does increased oxidative stress cause hypertension?” Diabetes care, vol. 31, pp. S185–S189, 2008.
- K. Yasunari, K. Maeda, M. Nakamura, and J. Yoshikawa, “Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein,” Hypertension, vol. 39, no. 3, pp. 777–780, 2002.
- F. Lacy, D. T. O'Connor, and G. W. Schmid-Schönbein, “Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension,” Journal of Hypertension, vol. 16, no. 3, pp. 291–303, 1998.
- C. Berry, C. A. Hamilton, M. J. Brosnan et al., “Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries,” Circulation, vol. 101, no. 18, pp. 2206–2212, 2000.
- R. M. Touyz and E. L. Schiffrin, “Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways,” Journal of Hypertension, vol. 19, no. 7, pp. 1245–1254, 2001.
- Y. Taniyama and K. K. Griendling, “Reactive oxygen species in the vasculature: molecular and cellular mechanisms,” Hypertension, vol. 42, no. 6, pp. 1075–1081, 2003.
- D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei, “Endothelium-dependent contractions and endothelial dysfunction in human hypertension,” British Journal of Pharmacology, vol. 157, no. 4, pp. 527–536, 2009.
- M. Félétou, R. Köhler, and P. M. Vanhoutte, “Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets,” Current Hypertension Reports, vol. 12, no. 4, pp. 267–275, 2010.
- Y. Hiroyuki, S. Masamichi, and W. Osamu, “Zinc deficiency and hypertension,” in Proceedings of the 18th Symposium on Trace Nutrients Research, pp. 67–71, 2001.
- J. Zicha, Z. Dobešová, and J. Kuneš, “Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions,” Journal of Hypertension, vol. 19, no. 2, pp. 247–254, 2001.
- X. Chen, R. M. Touyz, J. B. Park, and E. L. Schiffrin, “Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR,” Hypertension, vol. 38, no. 3, pp. 606–611, 2001.
- S. J. Duffy, N. Gokce, M. Holbrook et al., “Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension,” American Journal of Physiology, vol. 280, no. 2, pp. H528–H534, 2001.
- M. Boshtam, M. Rafiei, K. Sadeghi, and N. Sarraf-Zadegan, “Vitamin E can reduce blood pressure in mild hypertensives,” International Journal for Vitamin and Nutrition Research, vol. 72, no. 5, pp. 309–314, 2002.
- N. Tian, K. D. Thrasher, P. D. Gundy, M. D. Hughson, and R. D. Jr Manning, “Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitivity hypertension,” Hypertension, vol. 45, no. 5, pp. 934–939, 2005.
- P. Trinder, “Determination of blood glucose in blood using glucose oxidase with an alternative oxygen acceptor,” Annals of Clinical Biochemistry, vol. 6, pp. 24–25, 1969.
- C. C. Allain, L. S. Poon, and C. S. G. Chan, “Enzymatic determination of total serum cholesterol,” Clinical Chemistry, vol. 20, no. 4, pp. 470–475, 1974.
- N. W. Tietz, “Serum triglyceride determination,” in Clinical Guide to Laboratory Tests, pp. 554–556, W.B. Saunders, Philadelphia, Pa, USA, 2nd edition, 1990.
- M. Burstein, H. R. Scholnick, and R. Morfin, “Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions,” Journal of Lipid Research, vol. 11, no. 6, pp. 583–595, 1970.
- W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972.
- R. D. Abbott, P. W. F. Wilson, W. B. Kannel, and W. P. Castelli, “High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study,” Arteriosclerosis, vol. 8, no. 3, pp. 207–211, 1988.
- D. Koracevic, G. Koracevic, V. Djordjevic, S. Andrejevic, and V. Cosic, “Method for the measurement of antioxidant activity in human fluids,” Journal of Clinical Pathology, vol. 54, no. 5, pp. 356–361, 2001.
- W. G. Niehaus and B. Samuelsson, “Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation,” European Journal of Biochemistry, vol. 6, no. 1, pp. 126–130, 1968.
- D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985.
- S. Kadiri, “Tackling cardiovascular disease in Africa,” British Medical Journal, vol. 331, no. 7519, pp. 711–712, 2005.
- T. Ogihara, T. Asano, K. Ando et al., “High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats,” Hypertension, vol. 40, no. 1, pp. 83–89, 2002.
- B. M. S. Matthew, “Phenotypic expression of hypertension in rodent models through dietary manipulation,” Research diets, pp. 1–3, 2008.
- P. Meneton, X. Jeunemaitre, H. E. De Wardener, and G. A. Macgregor, “Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases,” Physiological Reviews, vol. 85, no. 2, pp. 679–715, 2005.
- H. Kobori, A. Nishiyama, Y. Abe, and L. G. Navar, “Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet,” Hypertension, vol. 41, no. 3 I, pp. 592–597, 2003.
- S. Kagota, A. Tamashiro, Y. Yamaguchi et al., “Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats,” British Journal of Pharmacology, vol. 134, no. 4, pp. 737–744, 2001.
- O. S. Adeniyi and A. A. Fasanmade, “Effect of dietary zinc supplementation on salt induced hypertension in rats,” International Journal of Pharmacology, vol. 2, no. 5, pp. 485–491, 2006.
- N. K. Lakshmana, J. Deepthi, Y. N. Rao, and K. M. Deedi, “Study of lipid profile, serum magnesium and blood glucose in hypertension,” Biology and Medicine, vol. 2, no. 1, pp. 6–16, 2010.
- U. K. Biswas and A. Kumar, “A study on lipid profile, oxidation stress and carbonic anhydrase activity in patients with essential hypertension,” Journal of Clinical and Diagnostic Research, vol. 4, no. 6, pp. 3414–3420, 2010.